<DOC>
	<DOCNO>NCT01984229</DOCNO>
	<brief_summary>This open-label study investigate whether multiple oral dos posaconazole affect single dose pharmacokinetics alectinib healthy volunteer .</brief_summary>
	<brief_title>A Study Effects Posaconazole Alectinib ( RO5424802 ) Pharmacokinetics Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Posaconazole</mesh_term>
	<criteria>Body mass index ( BMI ) 18 32 kilogram per square meter ( kg/m^2 ) Male volunteer must use effective contraception outline protocol Willingness abstain alcohol xanthinecontaining beverage food ( coffee , tea , cola , chocolate `` energy drink '' ) 72 hour prior first dose discharged Willingness avoid prolong sun exposure guard sunburn study followup Clinically significant medical history finding physical examination , vital sign , laboratory test result prior study start Positive screening test hepatitis B C , human immunodeficiency virus ( HIV ) , alcohol , drug abuse , tobacco Women childbearing potential , male pregnant lactate partner Regular smoking within 6 month prior first dose . Participants avoid smoky environment least 1 week prior cotinine screen Excessive alcohol consumption Use metabolic inducer ( include herbal St. John 's Wort ) within 4 week 5 halflives ( whichever longer ) first dose study medication , include limited : rifampin , rifabutin , glucocorticoid , carbamazepine , phenytoin phenobarbital Strenuous activity , sunbathing , contact sport allow 4 day prior entry clinical site study followup Participation investigational drug device study within 45 day ( 6 month biologic therapy ) prior first dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>